Compare GPC & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPC | RDY |
|---|---|---|
| Founded | 1928 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 11.6B |
| IPO Year | 1994 | 2001 |
| Metric | GPC | RDY |
|---|---|---|
| Price | $107.22 | $13.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $145.67 | $16.90 |
| AVG Volume (30 Days) | 2.1M | ★ 2.2M |
| Earning Date | 04-21-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.92% | 0.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $24,300,141,000.00 | N/A |
| Revenue This Year | $5.46 | $7.81 |
| Revenue Next Year | $3.80 | $3.20 |
| P/E Ratio | $231.02 | ★ $18.67 |
| Revenue Growth | ★ 3.46 | N/A |
| 52 Week Low | $96.08 | $12.82 |
| 52 Week High | $151.57 | $16.17 |
| Indicator | GPC | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 47.37 | 42.67 |
| Support Level | $96.08 | $13.32 |
| Resistance Level | $135.69 | $14.14 |
| Average True Range (ATR) | 2.60 | 0.23 |
| MACD | 1.45 | -0.04 |
| Stochastic Oscillator | 81.81 | 43.86 |
Genuine Parts sells aftermarket automotive parts (60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations, of which about two-thirds are independently owned and operated. We estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end-market sales derived from professional customers. Its industrial segment, primarily operating under the Motion name in the United States, is a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer customers.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.